Eptinezumab trials for Migraine

4 recruiting trials study Eptinezumab in trials listing Migraine in our tracked data. This is not a statement that it treats the condition.

Recruiting trials

Phase breakdown

Phase 3 3Not applicable 1

A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
NCT04965675 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 83 locations
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
NCT05164172 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 70 locations
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
NCT05897320 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 62 locations
China HeadAche DIsorders RegiStry
NCT05334927 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · 61 locations